EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The MODY-associated KCNK16 L114P mutation increases islet glucagon secretion and limits insulin secretion resulting in transient neonatal diabetes and glucose dyshomeostasis in adults

Arya Y Nakhe iD, Prasanna K Dadi, Jinsun Kim, Matthew T Dickerson, Soma Behera, Jordyn R Dobson, Shristi Shrestha, Jean-Philippe Cartailler, Leesa Sampson, Mark A Magnuson iD, David A Jacobson iD

eLife · 03.05.2024 · 12

DOI: 10.7554/elife.89967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 03.05.2024. Verfasst von Arya Y Nakhe und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, United States. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon, Glucose, Insulin Secretion. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gain-of-function mutation in the TALK-1 K + channel (p.L114P) is associated with maturity-onset diabetes of the young (MODY). TALK-1 is a key regulator of β-cell electrical activity and glucose-stimulated insulin secretion. The KCNK16 gene encoding TALK-1 is the most abundant and β-cell-restricted K + channel transcript. To investigate the impact of KCNK16 L114P on glucose homeostasis and confirm its association with MODY, a mouse model containing the Kcnk16 L114P mutation was generated. Heterozygous and homozygous Kcnk16 L114P mice exhibit increased neonatal lethality in the C57BL/6J and the CD-1 (ICR) genetic background, respectively. Lethality is likely a result of severe hyperglycemia observed in the homozygous Kcnk16 L114P neonates due to lack of glucose-stimulated insulin secretion and can be reduced with insulin treatment. Kcnk16 L114P increased whole-cell β-cell K + currents resulting in blunted glucose-stimulated Ca 2+ entry and loss of glucose-induced Ca 2+ oscillations. Thus, adult Kcnk16 L114P mice have reduced glucose-stimulated insulin secretion and plasma insulin levels, which significantly impairs glucose homeostasis. Taken together, this study shows that the MODY-associated Kcnk16 L114P mutation disrupts glucose homeostasis in adult mice resembling a MODY phenotype and causes neonatal lethality by inhibiting islet insulin secretion during development. These data suggest that TALK-1 is an islet-restricted target for the treatment for diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2GlucagonGlucoseInsulin SecretionMice, Inbred C57BLAnimalsMaleMiceAnimals, NewbornDisease Models, AnimalHomeostasisInsulinIslets of LangerhansMutationPotassium ChannelsPotassium Channels, Tandem Pore Domain

Stichwörter der Autor:innen

TALK-1calciumcomputational biologydevelopmental biologyglucagoninsulinisletmonogenic diabetesmousesystems biology

Substanzen

GlucagonGlucoseInsulinPotassium ChannelsKcnk16 protein, mousePotassium Channels, Tandem Pore Domain

Autor:innen und Institutionen

  • Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, United States.
  • Department of Chemistry, Vanderbilt University, Nashville, United States.
  • Center for Stem Cell Biology, Vanderbilt University, Nashville, United States.
  • Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States.

ORCID-Profile: Arya Y Nakhe, Mark A Magnuson, David A Jacobson

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Nakhe, A. Y., Dadi, P. K., Kim, J., Dickerson, M. T., Behera, S., Dobson, J. R., Shrestha, S., Cartailler, J. P., Sampson, L., Magnuson, M. A., & Jacobson, D. A. (2024). The MODY-associated KCNK16 L114P mutation increases islet glucagon secretion and limits insulin secretion resulting in transient neonatal diabetes and glucose dyshomeostasis in adults. eLife, 12. https://doi.org/10.7554/elife.89967

Vancouver

Nakhe AY, Dadi PK, Kim J, Dickerson MT, Behera S, Dobson JR, et al. The MODY-associated KCNK16 L114P mutation increases islet glucagon secretion and limits insulin secretion resulting in transient neonatal diabetes and glucose dyshomeostasis in adults. eLife. 2024;12. doi:10.7554/elife.89967

BibTeX
@article{Nakhe2024,
  author = {Nakhe, Arya Y and Dadi, Prasanna K and Kim, Jinsun and Dickerson, Matthew T and Behera, Soma and Dobson, Jordyn R and Shrestha, Shristi and Cartailler, Jean-Philippe and Sampson, Leesa and Magnuson, Mark A and Jacobson, David A},
  title = {The MODY-associated KCNK16 L114P mutation increases islet glucagon secretion and limits insulin secretion resulting in transient neonatal diabetes and glucose dyshomeostasis in adults},
  journal = {eLife},
  year = {2024},
  volume = {12},
  doi = {10.7554/elife.89967}
}
Kostenlos starten →